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This single center study assessed the performance of a novel solid rapidly-growing mycobacteria (RGM) medium
for the recovery of nontuberculous mycobacteria (NTM), especially Mycobacterium abscessus complex, in patients
with underlying bronchiectasis. A total of 297 mycobacterial sputa from 116 patients were plated directly on RGM
medium and, following decontamination, onto an agar biplate [Middlebrook 7H11 and Mitchison (selective)
agar] and into broth media (VersaTrek). The recovery of M. abscessus complex was increased by approximately
12% by implementation of the RGM medium. Contamination was reduced to 2% from 48% and 95% on routine
solid media and broth cultures respectively. Our study corroborated previous studies in that recovery of
M. abscessus complex was enhanced and contamination was virtually eliminated without the need for specimen
decontamination when utilizing RGM medium.1. Introduction
The number of patients with nontuberculous mycobacteria (NTM)
infections is rapidly increasing in the United States and globally [1].
Traditional culture methods for isolation of NTM have involved the same
methods with only slight modifications of decontamination of respiratory
samples that are used for the isolation of Mycobacterium tuberculosis.
However, often these methods used to eliminate contamination are too
harsh, either decreasing or completely nullifying the yield of NTM [2, 3,
4]. Contamination of cultures with fungal or other bacterial species is
also often problematic.
Recently an agar-based medium designed for the isolation of rapidly-
growing mycobacteria (RGM), specifically the Mycobacterium abscessus
complex, has been introduced [5]. Previous studies have shown that the
medium, designated RGM medium, has improved the recovery of RGM
and other NTM includingMycobacterium avium complex (MAC) although
studies with large numbers of MAC and other NTM have not yet been
reported [6, 7].
Our hospital and clinic are a major outpatient referral clinic for pa-
tients with bronchiectasis and NTM. We undertook an evaluation of theBrown-Elliott).
rm 17 September 2019; Accepte
is an open access article under tRGM medium and compared it to our routine detection method using a
biplate containing Middlebrook 7H11 agar and Mitchison 7H11 agar
(with antibiotics including carbenicillin, trimethoprim and amphotericin
B) and the VersaTrek broth detection system in accordance with current
Clinical and Laboratory Standards Institute (CLSI) guidelines [8].
2. Materials and methods
2.1. Materials
Middlebrook 7H11 agar and Mitchison selective (with carbenicillin,
trimethoprim and amphotericin B) 7H11 agar biplates (Becton-Dick-
inson, Sparks MD) were used for routine acid-fast bacilli (AFB) culture
along with the VersaTrek automated broth detection system (Thermo-
fisher, Cleveland, OH). RGM medium was prepared at the Freeman
Hospital, Newcastle upon Tyne, UK, as previously described [9] and
shipped to the University of Texas Health Science Center at Tyler where
specimen cultures were performed.d 15 October 2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A total of 297 respiratory samples from 116 patients with cystic
fibrosis (CF) and/or non-CF bronchiectasis were cultured. A total of 173/
297 specimens that required double processing for contamination were
submitted for mycobacterial culture between October 2017 and August
2018, due to prior incidences of contamination during culture for AFB.
During this time, 124 specimens that underwent single standard pro-
cessing from 20 patients were also included. Fourteen of the 116 (12%)
patients (with a total of 29 cultures) were known to have CF.
2.3. Sample processing
Each sample was divided into two parts. One aliquot was digested
using the AlphaTec NAC-PAC Unitary system (Alpha-Tec Systems Inc.,
Vancouver, WA) with N-acetyl-L-cysteine (0.5%) and decontaminated
with sodium hydroxide (2%). After centrifuging the samples at 3000 rpm
for 15 min the supernatant was then decanted. For selected samples (see
section 2.2), a second decontamination procedure using 5ml of 5% oxalic
acid was then added to each sample and incubated for 30 additional
minutes at room temperature, vortexing the samples every 10 min. After
neutralizing the samples with buffer, they were centrifuged at 3000 rpm
for 15 min. The supernatant was decanted, and the pellets were resus-
pended using the pellet resuspension buffer. The samples were inocu-
lated onto the biplate containing Middlebrook 7H11 and Mitchison
selective agar (approximately 0.3 μl onto each agar) as directed for AFB
processing [8]. Additionally, 0.5 ml of the concentrate was added to the
VersaTrek bottle. A 0.5 mL aliquot of MycoPVNA (polymyxin B, vanco-
mycin, nalidixic acid and amphotericin B) and 1 mL of growth supple-
ment were added to the bottle as directed by the manufacturer. The broth
and agar plates were incubated at 35 C up to 6 weeks and 3 weeks
respectively.
For the second aliquot of the untreated sample, a 100 μl aliquot of
specimen was pipetted directly (without digestion or decontamination)
onto the RGM medium and streaked for isolation. The plates were then
incubated at 30 C for 28 days.
2.4. Species identification
Isolates of RGM were identified to species level (and for M. abscessus
complex to subspecies level) using sequencing of region 5 of the rpoB
gene [10]. Isolates of MAC were identified using the AccuProbe system
(Hologic Inc, San Diego, CA). Slowly growing mycobacteria which were
not identified as MAC underwent partial 16S rRNA gene sequencing [11].
Statistical analysis was performed using the chi square method in
GraphPad. p values <0.05 were considered statistically significant.
This study was approved under an exempt protocol by the UniversityTable 1
Numbers of organisms recovered and rate of contamination from 297a respiratory sa
Species Total isolates 7H11/Mitchison selective agar
Isolates (n) % isolated
RGM (n ¼ 149)
M. abscessus complex 129 85 66
M. chelonae 1 0 0
M. mucogenicum 1 0 0
RGM (NOS)b 18 7 39
SGM (n ¼ 32)
M. avium complex 28 17 61
M. gordonae 3 0 0
M. paraffinicum 1 1 100
Total NTM 181
Contaminated samples 116 56 48
p values calculated by Chi-Square using GraphPad. Values < 0.05 were statistically s
Abbreviations: NA ¼ not applicable.
a There were 102 cultures with no growth.
b NOS ¼ not speciated but excluded as M. abscessus complex. RGM: Rapidly-growi
2of Texas Health Science Center at Tyler Institutional Review Board. Pa-
tient consent was not required since the testing performed was part of the
standard of care for patients with suspected M. abscessus lung disease.
3. Results
A total of 297 AFB cultures were processed using standard methods
with the addition of the RGM medium. Of the 297 cultures, 124 were
from a subset of patients who were involved in a specific treatment
protocol for treatment of M. abscessus complex refractory NTM lung
disease. A total of 129/181 (71%) total cultures were positive for
M. abscessus complex and 28/181 (15%) grew MAC (Table 1). The
sensitivity of RGMmediumwas 94% for recovery ofM. abscessus complex
compared with 66% for Middlebrook 7H11/Mitchison agar and 61% for
broth culture (p ¼ <0.05).
A total of 32/181 (18%) isolates of slowly growing mycobacteria
(SGM) including 17 isolates of MAC, one isolate of M. paraffinicum, and
7/181 (4%) other RGM (including those not identified to species levels)
were recovered from routine solid agar media (Middlebrook and
Mitchison agar) compared to 5/181 (3%) of SGM (MAC only) and 17/
181 (9%) of RGM (not M. abscessus complex) on RGM medium alone
(Table 1). Recovery of SGM (at 35 C) was superior in broth media which
recovered 19/181 (11%)MAC; 1/181 (0.6%)M. paraffinicum, and 3/181
(2%) M. gordonae. One isolate (0.6%) of RGM (not identified to species)
and a single M. mucogenicum were also recovered in broth medium only.
The recovery of MAC by RGMmedium was surprisingly low in this study
when compared with at least one large previous study [13] which em-
phasizes the importance of performing studies in different geographical
regions using a range of comparator methods.
Overall, contamination (bacterial, fungal and/or yeasts) of all types of
culture set ups was present in 116/297 (39%) of sputum cultures. Fifty-
six of 297 (19%) specimens that were plated on Middlebrook 7H11 and
Mitchison agar were contaminated compared to only 2/297 (0.6%) with
direct plating of sputum on RGM medium. Thirty-seven percent (110/
297) of the total cultures in broth medium were also contaminated. Of
the 116 cultures with contamination, 48% and 95% on routine agar
media and broth cultures respectively were contaminated compared to
only 2% contamination from the unprocessed samples cultured on RGM
medium (p < 0.05, Table 1).
4. Discussion
Traditional methods for M. tuberculosis from sputum culture have
hampered the recovery of NTM species andmade the clinical diagnosis of
NTM disease more difficult. The RGMmedium significantly enhances the
recovery of M. abscessus complex while streamlining the culture process
as there is no need for any kind of specimen processing, thus reducingmples cultured by different methods.
RGM medium Broth medium p
Isolates (n) % isolated Isolates (n) % isolated
121 94 79 61 <0.05
1 100 0 0 NA
0 0 1 100 NA
17 94 1 6 NA
5 18 19 68 <0.05
0 0 3 100 NA
0 0 1 100 NA
2 2 110 95 <0.05
ignificant.
ng mycobacteria. SGM: Slowly-growing mycobacteria.
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The currently recommended CLSI mycobacterial processing and cul-
ture method involves the use of N-acetyl-L-cysteine-NaOH decontamina-
tion and culture on both solid and liquid media for a minimum of 6 weeks
[8]. As previously mentioned, the decontamination process often has
substantial deleterious effects on the viability and recovery of NTM,
especially forM. abscessus complex [8]. Not only can this prevent, or delay
treatment strategies, but it may also under-estimate the prevalence and
clinical significance of RGM in patients with chronic lung disease [5].
This relatively simple implementation of the RGM medium into the
mycobacterial laboratory work flow may not only increase the yield of
M. abscessus complex in cultures with previous low numbers of
M. abscessus complex but may also identify M. abscessus complex in pa-
tients that are not identified by routine AFB culture alone. For all cul-
tures, the overall dramatic reduction of contamination in this study (only
2% on the RGM medium) compared to approximately 48% contamina-
tion on routine agar media and 95% in broth culture greatly influenced
the recovery of M. abscessus complex from otherwise uninterpretable
cultures. The relatively high contamination rate observed in this study is
partly attributable to the fact that 58% of samples (173/297) were from
patients who had previously submitted samples that had led to contam-
ination during routine culture for AFB. Although the number of patients
and cultures in the current studies is less than some previous studies, our
number of isolates ofM. abscessus complex was higher than any study we
are aware of to date [5, 6, 7, 12, 13].
There are major significant advantages to the use of RGM medium as
noted above. However, our study is not without limitations. Our study
population was small and some of the patients were well-known to our
institution, thus there was a high level of suspicion of significant NTM,
includingM. abscessus complex and theM. avium complex in the majority
of the AFB cultures.
Another limitation of our study was the lack of comparison of growth
at 30 C for the routine cultures as this is not the typical procedure for
recovery of RGM from respiratory cultures in our laboratory, which
cultures several thousand isolates of M. abscessus complex annually.
However, incubation of routine cultures at 30 C would be unlikely to
reduce the contamination rate.
Additionally, we did not compare the growth of isolates on the RGM
medium at 35 C. The lack of incubation of the RGM medium at 35 C
may account for the recovery of reduced numbers of SGM (e.g., MAC).
Although this may also be due to the fact that an un-concentrated sample
was used to inoculate RGM medium.
Although we were not able to prove enhanced recovery of NTM other
than the M. abscessus complex on RGM medium, the major aims of our
study, including the increased recovery of the M. abscessus complex and
the reduction of contamination of cultures, were achieved. When
M. absccesus was recovered on both RGM and conventional agars, the
time taken for colonies to develop was comparable (data not shown). The
use of RGM medium does not obviate the necessity for conventional AFB
cultures in order to detect other mycobacterial species including
M. avium complex.
In conclusion, our study corroborates previous studies in patients
with chronic pulmonary (bronchiectatic) disease where RGM medium
shows potential for transitioning the current AFB sputum culture pro-
cessing scheme into a less tedious, less time-consuming and more effec-
tive work flow with the expectation of enhanced recovery of NTM,
especially the M. abscessus complex [4, 5, 6, 7, 11, 12].
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